Welcome to LookChem.com Sign In|Join Free
  • or
C23H32N4O5 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1422185-84-9

Post Buying Request

1422185-84-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1422185-84-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1422185-84-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,2,1,8 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1422185-84:
(9*1)+(8*4)+(7*2)+(6*2)+(5*1)+(4*8)+(3*5)+(2*8)+(1*4)=139
139 % 10 = 9
So 1422185-84-9 is a valid CAS Registry Number.

1422185-84-9Upstream product

1422185-84-9Downstream Products

1422185-84-9Relevant academic research and scientific papers

Phthalocyanine-peptide conjugates: Receptor-targeting bifunctional agents for imaging and photodynamic therapy

Ranyuk, Elena,Cauchon, Nicole,Klarskov, Klaus,Guérin, Brigitte,Van Lier, Johan E.

, p. 1520 - 1534 (2013)

The synthesis of a series of new zinc phthalocyanine-peptide conjugates targeting the gastrin-releasing peptide (GRP) and integrin receptors is reported. Two alternative synthetic methods based on Sonogashira cross-coupling of an iodinated zinc phthalocyanine with acetylenic bombesin or arginine-glycine-aspartic acid (RGD) derivatives, either in solution or on solid phase, are presented. The water-soluble conjugates were screened for their photodynamic efficacy against several cancer cell lines expressing different levels of GRP and integrin receptors, and their intracellular localization was evaluated via confocal fluorescence microscopy. Variations in photocytotoxicity between the conjugates correlate to differences in hydrophobicity as well as receptor-mediated cell uptake. In the case of the phthalocyanine-bombesin conjugate, competition experiments confirm the involvement of the GRP receptor in both the phototherapeutic activity as well as intracellular localization. These findings warrant further in vivo studies to evaluate the potential of this conjugate as photosensitizer for photodynamic therapy (PDT) of cancers overexpressing the GRP receptor. Published 2013 by the American Chemical Society.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1422185-84-9